摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-Chloro-4-methyl-7-nitro-1,4-benzoxazin-3-one | 123282-04-2

中文名称
——
中文别名
——
英文名称
6-Chloro-4-methyl-7-nitro-1,4-benzoxazin-3-one
英文别名
——
6-Chloro-4-methyl-7-nitro-1,4-benzoxazin-3-one化学式
CAS
123282-04-2
化学式
C9H7ClN2O4
mdl
——
分子量
242.619
InChiKey
YEYWNLWIMRZTIS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    148 °C
  • 沸点:
    528.6±50.0 °C(Predicted)
  • 密度:
    1.529±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    16
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    75.4
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 1,2-di(cyclic) substituted benzene compounds
    申请人:Kawahara Tetsuya
    公开号:US20060276465A1
    公开(公告)日:2006-12-07
    A compound represented by the following general formula (1) or (100), a salt thereof or a hydrate of the foregoing has excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and is useful as a therapeutic or prophylactic agent for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R 10 represents optionally substituted cycloalkyl, etc., R 20-23 represent hydrogen, alkyl, alkoxy, etc., R 30-32 represent hydrogen, alkyl, oxo, etc., and R40 represents optionally substituted alkyl, etc. And A compound represented by the following general formula (1) or (100), a salt thereof or a hydrate of the foregoing has excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and is useful as a therapeutic or prophylactic agent for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R 10 represents 5- to 10-membered cycloalkyl etc. optionally substituted with hydroxyl etc., R 30 , R 31 and R 32 may be the same or different and each represents hydrogen etc., R 40 represents C1-10 alkyl etc. optionally substituted with hydroxyl etc., n represents an integer of 0, 1 or 2, X 1 represents CH or nitrogen, and R 20 , R 21 , R 22 and R 23 may be the same or different and each represents hydrogen etc.
    以下通式(1)或(100)所代表的化合物,其盐或水合物,具有优良的细胞黏附抑制作用或细胞浸润抑制作用,可用作治疗或预防与白细胞黏附和浸润相关的各种炎症性疾病和自身免疫疾病的药物,例如炎症性肠病(特别是溃疡性结肠炎或克罗恩病)、肠易激综合症、类风湿性关节炎、牛皮癣、多发性硬化症、哮喘和特应性皮炎。其中,R10表示可选取代的环烷基等,R20-23表示氢、烷基、烷氧基等,R30-32表示氢、烷基、氧代等,R40表示可选取代的烷基等。另外,以下通式(1)或(100)所代表的化合物,其盐或水合物,具有优良的细胞黏附抑制作用或细胞浸润抑制作用,可用作治疗或预防与白细胞黏附和浸润相关的各种炎症性疾病和自身免疫疾病的药物,例如炎症性肠病(特别是溃疡性结肠炎或克罗恩病)、肠易激综合症、类风湿性关节炎、牛皮癣、多发性硬化症、哮喘和特应性皮炎。其中,R10表示5-到10-成员环烷基等,可选取代为羟基等,R30、R31和R32可以相同也可以不同,每个表示氢等,R40表示可选取代的C1-10烷基等,可选取代为羟基等,n表示0、1或2,X1表示CH或氮,R20、R21、R22和R23可以相同也可以不同,每个表示氢等。
  • 1,2-di(cyclic) substituted benzene derivatives
    申请人:Kawahara Tetsuya
    公开号:US20060281747A1
    公开(公告)日:2006-12-14
    A compound represented by the following general formula (1) or (100), a salt thereof or a hydrate of the foregoing has excellent cell adhesion inhibitory action and cell infiltration inhibitory action. wherein R 10 represents 5- to 10-membered cycloalkyl etc. optionally substituted with hydroxyl etc., R 30 , R 31 and R 32 may be the same or different and each represents hydrogen etc., R 40 represents C1-10 alkyl etc. optionally substituted with hydroxyl etc., n represents an integer of 0, 1 or 2, X 1 represents CH or nitrogen, and R 20 , R 21 , R 22 and R 23 may be the same or different and each represents hydrogen etc.
    下列通式(1)或(100)所代表的化合物、其盐或其水合物具有优异的细胞粘附抑制作用和细胞渗透抑制作用。其中,R10代表5-至10-成员的环烷基等,可选地取代羟基等;R30、R31和R32可以相同也可以不同,且每个代表氢原子等;R40代表C1-10烷基等,可选地取代羟基等;n代表0、1或2的整数;X1代表CH或氮原子;R20、R21、R22和R23可以相同也可以不同,且每个代表氢原子等。
  • 1,2-DI(CYCLIC GROUP)SUBSTITUTED BENZENE DERIVATIVE
    申请人:Kawahara Tetsuya
    公开号:US20090156589A1
    公开(公告)日:2009-06-18
    A compound represented by the following general formula (1) or (100), a salt thereof or a hydrate of the foregoing has excellent cell adhesion inhibitory action and cell infiltration inhibitory action. wherein R 10 represents 5- to 10-membered cycloalkyl etc. optionally substituted with hydroxyl etc., R 30 , R 31 and R 32 may be the same or different and each represents hydrogen etc., R 40 represents C1-10 alkyl etc. optionally substituted with hydroxyl etc., n represents an integer of 0, 1 or 2, X 1 represents CH or nitrogen, and R 20 , R 21 , R 22 and R 23 may be the same or different and each represents hydrogen etc.
    下列普遍式(1)或(100)所代表的化合物、其盐或水合物,具有出色的细胞黏附抑制作用和细胞浸润抑制作用。其中,R10代表5-至10-成员环烷基等,可选择性地被氢氧基等置换,R30、R31和R32可以相同或不同,且每个代表氢等,R40代表C1-10烷基等,可选择性地被氢氧基等置换,n表示0、1或2的整数,X1代表CH或氮,R20、R21、R22和R23可以相同或不同,且每个代表氢等。
  • 1, 2-DI(CYCLIC GROUP)SUBSTITUTED BENZENE DERIVATIVE
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP1892238A1
    公开(公告)日:2008-02-27
    A compound represented by the following general formula (1) or (100), a salt thereof or a hydrate of the foregoing has excellent cell adhesion inhibitory action and cell infiltration inhibitory action. wherein R10 represents 5- to 10-membered cycloalkyl etc. optionally substituted with hydroxyl etc., R30, R31 and R32 may be the same or different and each represents hydrogen etc., R40 represents C1-10 alkyl etc. optionally substituted with hydroxyl etc., n represents an integer of 0, 1 or 2, X1 represents CH or nitrogen, and R20, R21, R22 and R23 may be the same or different and each represents hydrogen etc.
    由以下通式(1)或(100)代表的化合物、其盐或上述化合物的水合物具有极佳的细胞粘附抑制作用和细胞浸润抑制作用。 其中 R10 代表任选被羟基等取代的 5 至 10 元环烷基,R30、R31 和 R32 可以相同或不同且各自代表氢等,R40 代表任选被羟基等取代的 C1-10 烷基,n 代表 0、1 或 2 的整数,X1 代表 CH 或氮,R20、R21、R22 和 R23 可以相同或不同且各自代表氢等。
  • SASTRY, C. V. REDDY;RAO, K. SRINIVASA;KRISHNAN, V. S. H.;RASTOGI, K.;JAIN+, INDIAN J. CHEM. B , 28,(1989) N, C. 48-51
    作者:SASTRY, C. V. REDDY、RAO, K. SRINIVASA、KRISHNAN, V. S. H.、RASTOGI, K.、JAIN+
    DOI:——
    日期:——
查看更多